Related Experiment Video
Updated: May 11, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Potential role of annexin A7 in cancers
Chunmei Guo1, Shuqing Liu, Frederick Greenaway
1Department of Biotechnology, Dalian Medical University, Dalian 116044, China.
Abstract:
Annexin A7 (Anxa7) is a member of the multigene annexin superfamily of Ca(2+)-regulated and phospholipid-binding proteins. Accumulated evidence indicates that the deregulation, loss of heterozygosity (LOH) and subcellular localization of Anxa7 are associated with the occurrence, invasion, metastasis and progression of a variety of cancers. Anxa7 appears to have a tumor-suppression role in glioblastoma, glioblastoma multiforme (GBM), melanoma and prostate cancer (CaP) but, controversially and interestingly, Anxa7 also appears to promote the development and malignancies of liver cancer, gastric cancer (GC), nasopharyngeal carcinoma (NPC), colorectal cancer (CRC) and breast cancer (BC). The associations between Anxa7 and malignant tumors as well as potential mechanisms of action are summarized and discussed in current review. Anxa7 has potential for use as a biomarker for the diagnosis, treatment and prognosis of certain tumors.
Insights
Annexin A7 (Anxa7) plays a dual role in cancer, suppressing tumors in some cancers like glioblastoma but promoting malignancy in others such as liver and breast cancer. This review discusses its complex associations and potential as a cancer biomarker.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Annexin A7 (Anxa7) is a Ca(2+)-regulated, phospholipid-binding protein belonging to the annexin superfamily.
- Deregulation, loss of heterozygosity (LOH), and altered subcellular localization of Anxa7 are linked to various cancer hallmarks.
Purpose of the Study:
- To review and discuss the multifaceted roles of Annexin A7 (Anxa7) in different types of cancer.
- To explore the potential of Anxa7 as a diagnostic, therapeutic, and prognostic biomarker for malignant tumors.
Main Methods:
- Literature review and synthesis of existing research on Annexin A7 (Anxa7) in oncology.
- Analysis of studies investigating the association between Anxa7 expression/alterations and cancer development, invasion, metastasis, and progression.
Main Results:
- Anxa7 exhibits tumor-suppressive functions in glioblastoma, melanoma, and prostate cancer.
- Conversely, Anxa7 promotes tumorigenesis and malignancy in liver, gastric, nasopharyngeal, colorectal, and breast cancers.
- The complex and often opposing roles of Anxa7 in different cancer types are highlighted.
Conclusions:
- Annexin A7 (Anxa7) demonstrates context-dependent functions in cancer, acting as both a tumor suppressor and a promoter.
- Understanding these complex associations is crucial for developing Anxa7-based cancer biomarkers and therapeutic strategies.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Intrinsic Apoptotic Pathway
Non-Canonical Wnt Signaling Pathways
Selectins

